Comparison of AdvanSure TB/NTM PCR and COBAS TaqMan MTB PCR for Detection of Mycobacterium tuberculosis Complex in Routine Clinical Practice
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
The AdvanSure tuberculosis/non-tuberculous mycobacterium (TB/NTM) PCR (LG Life Science, Korea) and COBAS TaqMan Mycobacterium tuberculosis (MTB) PCR (Roche Diagnostics, USA) are commonly used in clinical microbiology laboratories. We aimed to evaluate these two commercial real-time PCR assays for detection of MTB in a large set of clinical samples over a two-year period. AdvanSure TB/NTM PCR and COBAS TaqMan MTB PCR were performed on 9,119 (75.2%) and 3,010 (24.8%) of 12,129 (9,728 respiratory and 2,401 non-respiratory) MTB specimens, with 361 (4.0%) and 102 (3.4%) acid-fast bacilli (AFB)-positive results, respectively. In MTB culture, 788 (6.5%) MTB and 514 (4.2%) NTM were identified. The total sensitivity and specificity of the AdvanSure assay were 67.8% (95% confidence interval [CI], 63.9-71.6) and 98.3% (95% CI, 98.0-98.6), while those of the COBAS TaqMan assay were 67.2% (95% CI, 60.0-73.8) and 98.4% (95% CI, 97.9-98.9), respectively. The sensitivities and specificities of the AdvanSure and COBAS TaqMan assays for AFB-positive and AFB-negative samples were comparable. Furthermore, the AdvanSure assay showed fewer invalid results compared with the COBAS TaqMan assay (5.0 vs. 20.4 invalid results/1,000 tests, P<0.001). AdvanSure assay represents a comparable yet more reliable method than COBAS TaqMan for the identification of mycobacteria in routine clinical microbiology.
Abstract
The AdvanSure tuberculosis/non-tuberculous mycobacterium (TB/NTM) PCR (LG Life Science, Korea) and COBAS TaqMan Mycobacterium tuberculosis (MTB) PCR (Roche Diagnostics, USA) are commonly used in clinical microbiology laboratories. We aimed to evaluate these two commercial real-time PCR assays for detection of MTB in a large set of clinical samples over a two-year period. AdvanSure TB/NTM PCR and COBAS TaqMan MTB PCR were performed on 9,119 (75.2%) and 3,010 (24.8%) of 12,129 (9,728 respiratory and 2,401 non-respiratory) MTB specimens, with 361 (4.0%) and 102 (3.4%) acid-fast bacilli (AFB)-positive results, respectively. In MTB culture, 788 (6.5%) MTB and 514 (4.2%) NTM were identified. The total sensitivity and specificity of the AdvanSure assay were 67.8% (95% confidence interval [CI], 63.9-71.6) and 98.3% (95% CI, 98.0-98.6), while those of the COBAS TaqMan assay were 67.2% (95% CI, 60.0-73.8) and 98.4% (95% CI, 97.9-98.9), respectively. The sensitivities and specificities of the AdvanSure and COBAS TaqMan assays for AFB-positive and AFB-negative samples were comparable. Furthermore, the AdvanSure assay showed fewer invalid results compared with the COBAS TaqMan assay (5.0 vs. 20.4 invalid results/1,000 tests, P<0.001). AdvanSure assay represents a comparable yet more reliable method than COBAS TaqMan for the identification of mycobacteria in routine clinical microbiology.
참고문헌 (14)
- Eurosurveillance editorial team, "WHO publishes Global tuberculosis report 2013. Euro Surveill 2013;18(43). pii:20615", ~ (2013)
- Soini H, "Molecular diagnosis of mycobacteria", Clin Chem, 47, pp.809~814 (2001)
- Cheng VC, "Molecular diagnostics in tuberculosis", Eur J Clin Microbiol Infect Dis, 24, pp.711~720 (2005)
- Bloemberg GV, "Evaluation of Cobas TaqMan MTB for direct detection of the Mycobacterium tuberculosis complex in comparison with Cobas Amplicor MTB", J Clin Microbiol, 51, pp.2112~2117 (2013)
- 김영진, "호흡기 검체를 이용한 AdvanSure TB", NTM Real Time PCR Kit의 항산균 진단 능력평가, 2008, pp.28(1), 34~38[DOI]
- 이혜영, "Assessment of the Quantitative Ability of AdvanSure TB", NTM Real-Time PCR in Respiratory Specimens by Comparison with Phenotypic Methods, 2014, pp.34(1), 51~55[DOI]
- 황상선, "LG AdvanSure TB", NTM Real-Time PCR Kit의 항산균 진단 수행 능력 평가, 2011, pp.14(2), 55~59[DOI]
- 조선영, "Comparison of Diagnostic Performance of Three Real-Time PCR Kits for Detecting Mycobacterium Species", Yonsei Medical Journal, 52(2), pp.301~306 (2011), 연세대학교의과대학
- Kim JH, "Evaluation of Cobas TaqMan MTB PCR for detection of Mycobacterium tuberculosis", J Clin Microbiol, 49, pp.173~176 (2011)
- Yang YC, "Evaluation of the Cobas TaqMan MTB test for direct detection of Mycobacterium tuberculosis complex in respiratory specimens", J Clin Microbiol, 49, pp.797~801 (2011)
- Causse M, "Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis", J Clin Microbiol, 49, pp.3065~3067 (2011)
- Park KS, "Comparison of the Xpert MTB", RIF and Cobas TaqMan MTB assays for detection of Mycobacterium tuberculosis in respiratory specimens, 2013, pp.51, 3225~3227
- Sarmiento OL, "Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis", J Clin Microbiol, 41, pp.3233~3240 (2003)
- Antonenka U, "Comparison of Xpert MTB", RIF with ProbeTec ET DTB and COBAS TaqMan MTB for direct detection of M. tuberculosis complex in respiratory specimens, 2013, pp.13, 280~